Noninvasive prenatal test for fetal chromosomal aneuploidies by massively parallel sequencing of cell-free fetal DNA in maternal plasma: The first clinical experience in Korea

Han, Sung-Hee; Yang, Young-Ho; Ryu, Jae-Song; Kang, Myung-Soo; Kim, Young-Jin; Lee, Kyoung-Ryul

추천

검색

자료유형: 학술저널

저자정보: Han, Sung-Hee (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories) Yang, Young-Ho (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories) Ryu, Jae-Song (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories) Kang, Myung-Soo (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories) Kim, Young-Jin (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories) Lee, Kyoung-Ryul (Division of Prenatal Molecular Genetics, Department of Laboratory Medicine, Seoul Clinical Laboratories)

저널정보: 대한의학유전학회 Journal of genetic medicine Journal of genetic medicine 제12권 제2호

발행연도: 2015.1

수록면: 85 - 91 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: Noninvasive prenatal test (NIPT) by massively parallel sequencing (MPS) of cell-free fetal DNA in maternal plasma marks a significant advancement in prenatal screening, minimizing the need for invasive testing of fetal chromosomal aneuploidies. Here, we report the initial clinical performance of NIPT in Korean pregnant women. Materials and Methods: MPS-based NIPT was performed on 910 cases; 5 mL blood samples were collected and sequenced in the Shenzhen BGI Genomic Laboratory to identify aneuploidies. The risk of fetal aneuploidy was determined by L-score and t-score, and classified as high or low. The NIPT results were validated by karyotyping for the high-risk cases and neonatal follow-up for low-risk cases. Results: NIPT was mainly requested for two clinical indications: abnormal biochemical serum-screening result (54.3%) and advanced maternal age (31.4%). Among 494 cases with abnormal biochemical serum-screening results, NIPT detected only 9 (1.8%) high-risk cases. Sixteen cases (1.8%) of 910 had a high risk for aneuploidy: 8 for trisomy 21, 2 for trisomy 18, 1 for trisomy 13, and 5 for sex chromosome abnormalities. Amniocentesis was performed for 7 of these cases (43.8%). In the karyotyping and neonatal data, no false positive or negative results were observed in our study. Conclusion: MPS-based NIPT detects fetal chromosomal aneuploidies with high accuracy. Introduction of NIPT as into clinical settings could prevent about 98% of unnecessary invasive diagnostic procedures.

#Noninvasive prenatal test #NIPT) #Cell-free fetal DNA #cffDNA) #Fetal chromosomal aneuploidies

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!